Literature DB >> 34866918

The Distribution and Source of MRDOs Infection: A Retrospective Study in 8 ICUs, 2013-2019.

Zhan-Jie Li1, Ke-Wei Wang2, Bo Liu1, Feng Zang1, Yu Zhang3, Wei-Hong Zhang1, Su-Ming Zhou4, Yong-Xiang Zhang1.   

Abstract

BACKGROUND: To analyze the distribution and source of MDROs infection in the ICUs and to provide a basis for formulating more effective prevention and control programs for MDROs.
METHODS: A retrospective investigation was conducted on MDROs infection in 8 ICUs of a large tertiary hospital from July 2013 to June 2019. A total of 2629 strains of MDROs isolated from 1701 inpatients were selected for analysis. The MDROs of the 8 ICUs were divided into two types of four categories according to source: out-of-hospital (out-of-hospital transfer and community acquisition) and in-hospital (in-hospital transfer and department acquisition) infections.
RESULTS: CRAB (41.84%) and CRE (35.07%) accounted for the majority of the infecting MDROs. The detection rates of MRSA, CRAB, CRPA and CRE were 61.24%, 83.75%, 43.01% and 30.15%, respectively. The top three infection sites of MDROs were the lower respiratory tract (81.10%), blood (6.70%) and abdominal cavity (5.80%). The out-of-hospital and in-hospital infection rates of MDROs were 50.51% and 49.49%, respectively; the out-of-hospital infection rates for MRSA, CRAB, CRPA and CRE were 43.56%, 55.91, 64.44% and 44.58%, respectively. The proportions of MRSA, CRAB, CRPA and CRE infections contracted in the department were 40.98%, 36.27%, 25.56% and 46.62%, respectively. There was a statistically significant difference between comprehensive ICU and specialized ICU wards as sources for CRAB infections (P < 0.001).
CONCLUSION: The main source of MDROs in the ICU is not the hospital itself entirely. It is particularly important to strengthen the identification of MDRO sources and implement more effective and accurate infection prevention and control measures.
© 2021 Li et al.

Entities:  

Keywords:  ICU; MDRO; intensive care unit; source

Year:  2021        PMID: 34866918      PMCID: PMC8636692          DOI: 10.2147/IDR.S332196

Source DB:  PubMed          Journal:  Infect Drug Resist        ISSN: 1178-6973            Impact factor:   4.003


  15 in total

Review 1.  Origins and evolution of antibiotic resistance.

Authors:  Julian Davies; Dorothy Davies
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

Review 2.  Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit.

Authors:  Lisa L Maragakis
Journal:  Crit Care Med       Date:  2010-08       Impact factor: 7.598

3.  Antibiotic-resistant bugs in the 21st century--a clinical super-challenge.

Authors:  Cesar A Arias; Barbara E Murray
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

4.  Improvement of a rapid direct blood culture microbial identification protocol using MALDI-TOF MS and performance comparison with SepsiTyper kit.

Authors:  Francesca Di Gaudio; Serena Indelicato; Sergio Indelicato; Maria Rita Tricoli; Giuseppe Stampone; David Bongiorno
Journal:  J Microbiol Methods       Date:  2018-10-26       Impact factor: 2.363

Review 5.  What is the renal replacement method of first choice for intensive care patients?

Authors:  R Vanholder; W Van Biesen; N Lameire
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

6.  Sepsis in European intensive care units: results of the SOAP study.

Authors:  Jean-Louis Vincent; Yasser Sakr; Charles L Sprung; V Marco Ranieri; Konrad Reinhart; Herwig Gerlach; Rui Moreno; Jean Carlet; Jean-Roger Le Gall; Didier Payen
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

Review 7.  Hospital-acquired infections due to gram-negative bacteria.

Authors:  Anton Y Peleg; David C Hooper
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

8.  Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit.

Authors:  Kaweesak Chittawatanarat; Wuttipong Jaipakdee; Narain Chotirosniramit; Kamtone Chandacham; Tidarat Jirapongcharoenlap
Journal:  Infect Drug Resist       Date:  2014-08-16       Impact factor: 4.003

Review 9.  What's new in multidrug-resistant pathogens in the ICU?

Authors:  Gabor Zilahi; Antonio Artigas; Ignacio Martin-Loeches
Journal:  Ann Intensive Care       Date:  2016-10-06       Impact factor: 6.925

Review 10.  What Healthcare Workers Should Know about Environmental Bacterial Contamination in the Intensive Care Unit.

Authors:  Vincenzo Russotto; Andrea Cortegiani; Teresa Fasciana; Pasquale Iozzo; Santi Maurizio Raineri; Cesare Gregoretti; Anna Giammanco; Antonino Giarratano
Journal:  Biomed Res Int       Date:  2017-10-29       Impact factor: 3.411

View more
  3 in total

1.  Effectiveness of an Active and Continuous Surveillance Program for Intensive Care Units Infections Based on the EPIC III (Extended Prevalence of Infection in Intensive Care) Approach.

Authors:  Giorgia Montrucchio; Gabriele Sales; Giulia Catozzi; Stefano Bosso; Martina Scanu; Titty Vita Vignola; Andrea Costamagna; Silvia Corcione; Rosario Urbino; Claudia Filippini; Francesco Giuseppe De Rosa; Luca Brazzi
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.964

2.  Study on the Detection and Infection Distribution of Multidrug-Resistant Organisms in Different Specimens.

Authors:  Zhanjie Li; Ying Zhang; Weihong Zhang; Yongxiang Zhang; Suming Zhou; Wensen Chen; Yun Liu
Journal:  Infect Drug Resist       Date:  2022-10-14       Impact factor: 4.177

3.  Clinical prediction models for multidrug-resistant organism colonisation or infection in critically ill patients: a systematic review protocol.

Authors:  Yi Wang; Yanyan Xiao; Qidi Yang; Fang Wang; Ying Wang; Cui Yuan
Journal:  BMJ Open       Date:  2022-09-29       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.